Molecular targets for breast cancer therapy and prevention
Johannes Bange, Esther Zwick
& Axel Ullrich
Max-Planck-Institut of Biochemistry, Department of Molecular Biology Martinsried, Germany ullrich@biochem.mpg.de
The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.
